The IL-32 concentration in tumor (p < 0.00001) and adjacent tissue (p < 0.00001) as well as fold-change in concentration (tumor-to-adjacent) were significantly lower in CRC as compared to GC and ESCC (Figure 5). This evidence concerns the gene IL32 and colorectal carcinoma.